Evolv Co-Founder Apologizes For CEO Saying Things That "Shouldn't Have Been Said"
An Evolv co-founder and executive apologized in a media interview publicly for statements made by Evolv's CEO about the capabilities of its technology.
Some of Evolv's CEO's claims that IPVM has covered over the past few years:
- Evolv CEO Lies: "Unless You Are Carrying A Weapon, You Get To Walk Right In"
- Evolv CEO's "Signatures For All The Weapons In The World" Claim Analyzed
- Evolv's CEO School Backpack Claim Contradicted In Own Video
- Evolv CEO Admitted Subways Not A Good Use Case 2 Weeks Before NYC Subway Partnership
- Evolv CEO Tells Investors: "Know That Nobody Has A Weapon"
- Evolv CEO: "Thank Goodness Nothing Tragic Has Happened Yet, But It's Probably Just A Matter Of Time."
In this report, we examine the statements.
"Peter **** ****** ****...*******'* **** **** ****."
** * *** *, ****, *******, ***** **-******* *** ***** ********** Officer**** ********************* ***********'********** **** "* ****** ** ******* say[ing] ***** *** **** ***** *** misleading ******."
**********, ********** ******** ********* *** ***** ******'*********** ***** ***** *** *** **** accurate.
***** **** * ****** ** ********* wherePeter **** ****** **** ***** ********, I would say, shouldn’t **** **** ****. We ** ********* *** ****. We own that. [emphasis added]
****** "***** ****" ******** **** ***** will "****** ****" ********* * **** *******. ********** ** ***********, ****** ****, in ****, "**'* ***** ************ *** to ** **** *********. **** ***, the ***** **** *** **** **********."
*** ********** **** **** ** ****,it’s *** **** ******. The system “has settings that will find all types of firearms,” Ellenbogen said. But when used in a stadium or a school, it’s ***** ************ *** ** ** **** *********. This way the ***** **** *** **** **********. But this setting increases *** ********** **** **** ******* *** *** *******. [emphasis added]
**** ** ********** **** **** **** uncovered ***** *** ************* ******* ******* ** ******** **********. *****, *** ****** *** ********** reinforce ****, "** ******** *** ***** balance ******* *********** *** ********. '***’* not ***** *** ******* ** ** the ***** ** *** ****,' ** said."
"Own[ing]" ************* ***** ***** ***/*** *************
**********'* ********** *** *****'* *****-**** ************** that *** *** *** *** ********** describe *** **********.
***** ** ** ******** **** ***** is ********* ** ** **** ********, Evolv *** **** **** ** ******** *** *** *** ******* ************* it, *** ****** ***** ****** *********** ********** *****.
Extraordinarily **** **********
******, ** ****'* **********, ** ********** publicly ********* *** *** ********** ** their *** (****** **** ****** *** companies ***** ************ ** ********** ********).
**** ****** ********* ***** *** ****-**** future ** *****'* ***. ** *** public **** ** *** ******* ******** a ****** *******, **** **** ********** merit ********** ** ** *** ****** face ** *** *******?
**** *** ***** ********** **** ***** partners ***** ***** ******, ********* *** partner********** ** **** ****"*****'* *** ** *** *******’* ***** enemy." ***** *****'* ***'* ********** *** problematic, **** ** *****'* ****** ********* has **** ** ****, *.*.,***** ** ******** ****** *** ********* Marketing,***** ******** *******,***** ***** "*******-**** *****," ******** ** "Safe *****," *** "***** *****,"***.
Sign ** ******** ********* **************
** ** *** **** ******* ** a **** ** ***** ******** **** conservative ** *** *********, ***** ***** be * ********. *******, ***** ******* has ******* ********** **** ***** ** deception *** ** ******* ** ** seen *** ************ *** ******** ***** intends ** ****** ** *** *********.
Evolv ********* "**** *** *******"
******* ********* ********* ** ******'* ***** and ********** **********, ********** ******** *****'* stance **** ***** *** ********** ********* does *** ****** ******** ********* ******* of *****'* *********** **** **********.
** ***** **** ******’* ************* ***** not **** ****** *** ********* *** school ******** ********* *** **** ******** decisions ***** ***** ********. “**** ** talk ** *** *********,” ** ****, “not **** **we **** **** ******* **** ** **** *** *****’* ** … **** ** *** ********* **** **** *** *******. They’re not buying it from a banner ad. [emphasis added]
**** ******** *********** ***** ***** * license ** *** ** **** **** say ** ****** ***** *** ******, even ** **** ***** *** ***** in *******, ***** ******* *** *** public ******** *** *** ** ******** in ****** *****, ** **** ** Evolv's ********* ** * ********-****** *******.
Evolv ********* "**** *** *******"
******* ********* ********* ** ******'* ***** and ********** **********, ********** ******** *****'* stance **** ***** *** ********** ********* does *** ****** ******** ********* ******* of *****'* *********** **** **********.
^ **** ** ****. ******** *** users ***** ****** *** ******* *****. That ****, ** ***** ** **** if *** *** **** ************** *** this. *** **** **** ** ******** not ** *** **********.
*** ***** *** ******* ************ ** continue ** ***** ****** ******** ******** even **** **** ********* **** ** problems/that **** **** *******/***. ************ ********** end ***** **** *******, ***** *** a ***** ********** ** *****'* *********.
*** ***** ** *** **** ** admit **** ***** **** ** **** people **** *** *******, ** **** millions ** ****** ***** **** *** used ****.
**** ** *** *** **** ***** school ******** **** *** ******** ****** problems** *****'* **************, *** ***** ** ** ******* he *** *** *********** *** **, the ******** ************** ***.
* *** ***** ** **** *** occasions **** * ****** *** ******** any ********** ******** *** *********** ** my **** ** ****.
** *** ** ****, ******* ********* admit ********* ** ******** *** **** rarely ********. **** **** ** *****, fever *******.
***** ******* ** ******** ******* * general ***** ** ******** **** **** end ***** **** ********. ********* ****** or ********** ** ********* *************** ****** a ******* **** **** **** **** good ** ** *******.
*** **** ***** **** ** ********* the ******** ** ***** ***** *** their ********* ****** ** ** *** user’s ********. ****** ********** ** **** of * ****** ** *** ***** are ********* *** ***** ***** ***** concerns ***** ** ****.
*****'* ** ****** ***** ***** ********* trust **** ** ********** *********** **** while ************** ***** ******* *************, ****.
* ****** **** ** ********, ********* ***** ***** **'* **** more ******** ***:
***, *** ***** ******* ***** **-******* remark ***** *** **** ***** ** from ********* * **** **** ****:
****'* ***** ** ******* *****. ******, every ****** ***** **** **** **** and *** ****** **** ******* ******* NDAs ** ** ******* ** ******* details ** ***** ********'* ***********, *** that's ******* ** ****** *** *** public ** ** ****** **** *** to ****** ****** *** ** ***** own ****** **** ******* **** *** experience ** ****** **** ** **** who *** *** ****** ***** **** thousands ** ***** *********** ***** / "weapons" *********.